NCI - National Cancer Institute
The overall goal of this project is the commercialization of a novel, first-in-class small molecule to safely and effectively treat rare, high-risk, pediatric tumors; and to increase survival rates without long-term side effects which arise from current treatments. The Phase I efforts focused on rhabdomyosarcoma, an extremely rare pediatric cancer. The goals of this effort are to expand the patient pool for a pediatric clinical trial to include other high risk sarcomas and blastomas to decrease accrual times, to identify which drugs can safely and effectively be used in combination with drug candidate as pediatric oncologists are reluctant to give new drugs as single agents; and to complete IND-enabling studies and file an IND.
Up to $3.0M
2027-09-14
We'll draft the complete application against NCI - National Cancer Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Subscribe for Pro access · Includes AI drafting + templates + PDF export
Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness
NIMH - National Institute of Mental Health — up to $18.3M
COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I
NCI - National Cancer Institute — up to $15.1M
Leveraging Artificial Intelligence to Predict Mental Health Risk among Youth Presenting to Rural Primary Care Clinics
NIMH - National Institute of Mental Health — up to $15.0M
Feasibility of Genomic Newborn Screening Through Public Health Laboratories
OD - NIH Office of the Director — up to $14.4M
WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL COORDINATING CENTER - TASK AREA A AND A2
NHLBI - National Heart Lung and Blood Institute — up to $10.2M
Metal Exposures, Omics, and AD/ADRD risk in Diverse US Adults
NIA - National Institute on Aging — up to $10.2M